Aurinia Pharmaceuticals Inc.
Clinical trials sponsored by Aurinia Pharmaceuticals Inc., explained in plain language.
-
Lupus kidney drug study in kids ends early – only 4 enrolled
Disease control TerminatedThis study aimed to check the long-term safety of voclosporin in adolescents and children with lupus nephritis, a kidney disease caused by lupus. Participants had already completed 24 weeks of treatment in an earlier study and were followed for up to 12 more months. However, the …
Phase: PHASE3 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Kidney drug trial for young lupus patients halted early
Disease control TerminatedThis study tested the drug voclosporin in teenagers and children with lupus nephritis, a kidney disease caused by lupus. The goal was to see if the drug could improve kidney function better than a placebo. However, the study was stopped early after enrolling only 9 participants, …
Phase: PHASE3 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 07:19 UTC